Pellets Pharma

Hyderabad, India Founded: 2002 • Age: 24 yrs
Specializes in developing and manufacturing modified release pellets for various APIs.

About Pellets Pharma

Pellets Pharma is a company based in Hyderabad (India) founded in 2002 by Radha Krishna Pathuru. It operates as a B2B. The company has 177 employees. Pellets Pharma operates in a competitive market with competitors including Inventia Healthcare, Capsugel, Suzhou Ze Jing Biological Pharmaceutical, Zim Labs and Adare Pharma Solutions, among others.

  • Headquarter Hyderabad, India
  • Employees 177
  • Founders Radha Krishna Pathuru
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Website pelletspharma.com
  • Social LinkedIn
  • Legal Name Pellets Pharma Limited
  • Date of Incorporation 11 Mar, 2004
  • Jurisdiction Hyderabad, Telangana, India
Key Metrics
  • Annual Revenue
    ₹72.09 Cr

    FY 2024 · +2% YoY

  • Net Profit
    ₹23.12 Cr

    FY 2024 · 32% margin

  • EBITDA
    ₹34.17 Cr

    FY 2024 · 47% margin

  • Employee Count
    177

Board of directors of Pellets Pharma Limited (Pellets Pharma)

Pellets Pharma Limited is the primary company behind Pellets Pharma. The board of Pellets Pharma Limited currently have 4 directors; the longest-serving is Pathuru Sreelatha, appointed in 2004. 5 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Pathuru Sreelatha
DIN 01950248
Managing Director11 Mar 200422 yrs 6 moPellets Pharma Limited
Pathuru Vamsi Krishna
DIN 08513199
Whole-time director18 Jul 20197 yrs 2 moPellets Pharma Limited
Srinivasa Rao Jetti
DIN 06946369
Whole-time director30 Sep 20242 yrsPellets Pharma Limited
Pathuru Aasritha
DIN 09388413
Director30 Sep 20242 yrsPellets Pharma Limited

People of Pellets Pharma

4 people are tracked at Pellets Pharma (1 in leadership, 3 in team); the tracked headcount is 177.

NameRoleGroup
Radha Krishna Pathuru
Founder, CEOLeadership
Malla Reddy Durgempudi
ManagerTeam
Pushpa Latha
ExecutiveTeam
Ashok Kumar Tekkali
Manager-adlTeam
Premium access

Complete people profiles for Pellets Pharma

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Financials of Pellets Pharma

Figures of Pellets Pharma Limited, the primary company behind Pellets Pharma, for FY 2024. Revenue was ₹72.09 Cr (+2% year on year). Net profit was ₹23.12 Cr (32% margin). EBITDA was ₹34.17 Cr (47% margin). Revenue has grown at a compounded annual rate of +18% over three years and +7% over five years.

  • ₹72.09 CrRevenue · FY 2024 · +2% YoY
  • ₹23.12 CrNet profit · 32% margin
  • ₹34.17 CrEBITDA · 47% margin
  • ₹83.4 LakhPaid-up capital
  • 177Employees (provident fund records)
  • +18%Revenue CAGR, 3 years
  • +7%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Pellets Pharma Limited are on its company page.

Premium access

Detailed financial statements for Pellets Pharma

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Competitors of Pellets Pharma

Pellets Pharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Inventia Healthcare, Capsugel, Suzhou Ze Jing Biological Pharmaceutical, Zim Labs and Adare Pharma Solutions, among others.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
inventiahealthcare.com1985Mumbai, India$42.49M980
Oral solid drug delivery systems are manufactured and developed.
capsugel.com1875Morristown, United States––
Dosage forms are delivered for preclinical, clinical, and commercial supply.
zelgen.com2009Suzhou, China$61.92M–
Company developing small molecules & eukaryotic cell based recombinant protein drugs
zimlab.in1989Nagpur, India$8.2M598
Solid and semisolid dosage forms are developed and manufactured.
adarepharmasolutions.com2015Lawrence Township, United States–217
CDMO manufacturing solid drugs
cpc.com1971Hauppauge, United States–27
Product development, manufacturing and packaging services
lotuspharm.com1966Taipei, Taiwan––
Contract manufacturing for oral solid formulations is offered.
tedorpharma.com2001Cumberland, United States$1.48M–
Turnkey development services for solid dosage forms are provided.
halewoodlabs.com1984Ahmedabad, India–348
Provides contract manufacturing services for food, pharmaceuticals, and related products globally.
norwichpharma.com1887Norwich, United States––
Offers a full range of solid dose manufacturing and packaging
Premium access

Detailed competitors of Pellets Pharma

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Similar companies to Pellets Pharma

10 companies that operate in the same segment as Pellets Pharma (Pharmaceuticals & Distribution), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Pharmaceutical products are manufactured and marketed worldwide.
1891Kenilworth, Warwickshire, United Kingdom–USD 64.93 B781
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed.
2014New York, New York, United StatesUSD 1.3 BUSD 8.26 M750
Developer of pharmaceutical products for treating multiple diseases
1980Thousand Oaks, California, United States–USD 33.23 B28,000
Biopharmaceutical research and drug development are conducted globally by AbbVie.
2012Chicago, Illinois, United States–USD 61.16 B55,000
Traditional pharmaceutical medicines are developed for multiple health fields.
1876United States–USD 65.18 B47,000
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others
1987Foster City, California, United States–USD 29.45 B17,600
Novel therapeutics are discovered using an AI-enabled drug platform.
2013New York, New York, United StatesUSD 456.66 MUSD 74.68 M–
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology.
1993San Francisco, California, United StatesUSD 215.5 MUSD 29.62 M225
Developer of medical devices, generic pharmaceuticals, and nutrition products
1888Libertyville, Illinois, United States–USD 44.33 B3,710
Medicines and health products are retailed through pharmacy outlets.
2006Hyderabad, Telangana, IndiaUSD 268.78 MUSD 734.57 M25,010
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Pellets Pharma

Pellets Pharma was founded in 2002.

Pellets Pharma is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.

Radha Krishna Pathuru is the current CEO of Pellets Pharma. They have also founded this company.

Pellets Pharma has 177 employees.

The primary company behind Pellets Pharma, Pellets Pharma Limited, reported revenue of β‚Ή72.09 Cr for FY 2024, up 2% year on year.

Pellets Pharma, led by Radha Krishna Pathuru as Founder, CEO, specializes in providing healthcare solutions, producing pharmaceutical products, drug manufacturing, and pellet development. Specializes in developing and manufacturing modified release pellets for various APIs. The team drives innovation, quality service, and sustainable practices to achieve excellence and client satisfaction.

Pellets Pharma's top competitors include Inventia Healthcare, Zim Labs and Lotus.

Pellets Pharma operates through Pellets Pharma Limited.

The legal entities of Pellets Pharma currently have 4 directors, including Srinivasa Rao Jetti, Pathuru Sreelatha, Pathuru Vamsi Krishna and others.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available